ASLAN Pharmaceuticals PE Ratio 2017-2021 | ASLN

Current and historical p/e ratio for ASLAN Pharmaceuticals (ASLN) from 2017 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ASLAN Pharmaceuticals PE ratio as of October 26, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

ASLAN Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-27 1.67 0.00
2021-06-30 3.30 $-0.30 0.00
2021-03-31 3.35 $-0.40 0.00
2020-12-31 1.83 $-0.35 0.00
2020-09-30 1.90 $-1.08 0.00
2020-06-30 2.00 $-1.09 0.00
2020-03-31 1.02 $-1.24 0.00
2019-12-31 2.03 $-1.31 0.00
2019-09-30 1.73 $-0.78 0.00
2019-06-30 3.07 $-0.82 0.00
2019-03-31 4.29 $-0.92 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.058B $0.003B
ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases. The company's product portfolio includes Varlitinib, ASLAN004, ASLAN002 and ASLAN003 both are in clinical stage. ASLAN Pharmaceuticals Limited is based in Singapore.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86